| Literature DB >> 22874516 |
David Chadwick1, Alastair Stanley, Stephen Sarfo, Lambert Appiah, Michael Ankcorn, Geraldine Foster, Uli Schwab, Richard Phillips, Anna M Geretti.
Abstract
This study evaluated the outcome of first-line antiretroviral therapy among 35 Ghanaians with occult HBV/HIV co-infection, comparing them over 2 years to 120 patients with HBsAg+ HBV/HIV co-infection and 230 patients without HBV co-infection. Increases in CD4 cell count and BMI were similar, whereas elevations of hepatic transaminases were more frequent in both the occult HBV and HBsAg+ patients. Occult HBV/HIV co-infection appears not to impact adversely on response to antiretroviral therapy in Ghana.Entities:
Mesh:
Substances:
Year: 2013 PMID: 22874516 DOI: 10.1097/QAD.0b013e3283589879
Source DB: PubMed Journal: AIDS ISSN: 0269-9370 Impact factor: 4.177